Yoseph Shaaltiel
2012
In 2012, Yoseph Shaaltiel earned a total compensation of $1.6M as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 286% increase compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $608,826 |
| Salary | $283,655 |
| Stock Awards | $409,838 |
| Other | $67,257 |
| Total | $1,594,576 |
Shaaltiel received $608.8K in option awards, accounting for 38% of the total pay in 2012.
Shaaltiel also received $225K in bonus, $283.7K in salary, $409.8K in stock awards and $67.3K in other compensation.
Rankings
In 2012, Yoseph Shaaltiel's compensation ranked 4,341st out of 11,487 executives tracked by ExecPay. In other words, Shaaltiel earned more than 62.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,341 out of 11,487 | 62nd |
Division Manufacturing | 1,501 out of 4,253 | 65th |
Major group Chemicals And Allied Products | 342 out of 1,203 | 72nd |
Industry group Drugs | 209 out of 925 | 77th |
Industry Biological Products, Except Diagnostic Substances | 37 out of 165 | 78th |
Source: SEC filing on October 9, 2014.
Shaaltiel's colleagues
We found four more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2012.